Pasireotide diaspartate

Modify Date: 2024-01-09 12:07:58

Pasireotide diaspartate Structure
Pasireotide diaspartate structure
Common Name Pasireotide diaspartate
CAS Number 820232-50-6 Molecular Weight 1313.412
Density N/A Boiling Point N/A
Molecular Formula C66H80N12O17 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Pasireotide diaspartate


Pasireotide, also known as SOM230, is an orphan drug approved for the treatment of Cushing's disease in patients who fail or are ineligible for surgical therapy. It was developed by Novartis. Pasireotide is a somatostatin analog with a 40-fold increased affinity to somatostatin receptor 5 compared to other somatostatin analogs.

 Names

Name Pasireotide diaspartate
Synonym More Synonyms

 Chemical & Physical Properties

Molecular Formula C66H80N12O17
Molecular Weight 1313.412
Exact Mass 1312.576416

 Synonyms

I4P76SY3N4
L-Aspartic acid, compd. with cyclo[(2S)-2-phenylglycyl-D-tryptophyl-L-lysyl-O-(phenylmethyl)-L-tyrosyl-L-phenylalanyl-(4R)-4-[[[(2-aminoethyl)amino]carbonyl]oxy]-L-prolyl] (2:1)
pasireotide aspartate
Pasireotide diaspartate
L-Aspartic acid - cyclo[(2S)-2-phenylglycyl-D-tryptophyl-L-lysyl-O-benzyl-L-tyrosyl-L-phenylalanyl-(4R)-4-{[(2-aminoethyl)carbamoyl]oxy}-L-prolyl] (2:1)
Signifor
Top Suppliers:I want be here



Get all suppliers and price by the below link:

Pasireotide diaspartate suppliers

Pasireotide diaspartate price